Mdsc targeting with gemtuzumab ozogamicin restores t cell immunity and immunotherapy against cancers

HIGHLIGHTS

• who: SC et al. from the Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK have published the article: MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers, in the Journal: (JOURNAL)
• what: The authors investigate potential clinically relevant targets for depleting MDSCs to reactivate T_cell immunity. Although the authors focused on screening the library for potential clinical targets to deplete MDSCs, the authors suggest such data will also allow for an improved understanding of the underlying biology of M-MDSCs and G-MDSCs and could identify other strategies to . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.